Erythrocin Stearate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Erythrocin Stearate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

USE IN SPECIFIC POPULATIONS


ERYTHROCIN STEARATE DESCRIPTION



Erythrocin Stearate

Inactive Ingredients






CLINICAL PHARMACOLOGY





Microbiology


INDICATIONS AND USAGEsection.




















but their clinical significance is unknown.
























INDICATIONS & USAGE


















Prophylaxis






ERYTHROCIN STEARATE CONTRAINDICATIONS



WARNINGS







PRECAUTIONS

General

CLINICAL PHARMACOLOGYandWARNINGS.)




INFORMATION FOR PATIENTS



DRUG INTERACTIONS






















CONTRAINDICATIONS.)

CONTRAINDICATIONS.) In addition, deaths have been reported rarely with concomitant administration of terfenadine and erythromycin.
CONTRAINDICATIONS).

DRUG & OR LABORATORY TEST INTERACTIONS


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY


PREGNANCY





LABOR & DELIVERY


NURSING MOTHERS


PEDIATRIC USE

INDICATIONS AND USAGEandDOSAGE AND ADMINISTRATION.

GERIATRIC USE

ADVERSE REACTIONSandDOSAGE AND ADMINISTRATION).
ADVERSE REACTIONS).
PRECAUTIONS - Drug Interactions).



ERYTHROCIN STEARATE ADVERSE REACTIONS

WARNINGS.)
WARNINGS.)




OVERDOSAGE



DOSAGE & ADMINISTRATION



Adults
The usual dosage is 250 mg every 6 hours; or 500 mg every 12 hours. Dosage may be increased up to 4 g per day according to the severity of the infection. However, twice-a-day dosing is not recommended when doses larger than 2 g daily are administered.


Children






Conjunctivitis of the Newborn Caused by Chlamydia trachomatis


Pneumonia of Infancy Caused by Chlamydia trachomatis


Urogenital Infections During Pregnancy Due to Chlamydia trachomatis


For Adults With Uncomplicated Urethral, Endocervical, or Rectal Infections Caused by Chlamydia trachomatis, When Tetracycline is Contraindicated or Not Tolerated


For Patients With Nongonococcal Urethritis Caused by Ureaplasma urealyticum When Tetracycline is Contraindicated or Not Tolerated


Primary Syphilis


Acute Pelvic Inflammatory Disease Caused by N. gonorrhoeae


Intestinal Amebiasis







Pertussis


Legionnaires' Disease

HOW SUPPLIED


Abbottlogoand the Abbo-Code designation ES:
NDC0074-6346-20)
NDC0074-6346-53)
Abbottlogoand the Abbo-Code designation ET:
NDC0074-6316-13)

STORAGE AND HANDLING


REFERENCES






PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Erythrocin Stearate

Erythrocin Stearate

ERYTHROMYCIN STEARATE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-360(NDC:0074-6316)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ERYTHROMYCIN STEARATE ERYTHROMYCIN 500 mg

Inactive Ingredients

Ingredient Name Strength
STARCH, CORN
FD&C RED NO. 3
magnesium hydroxide
POLACRILIN POTASSIUM
povidone
propylene glycol
SORBITAN MONOOLEATE
titanium dioxide
VANILLIN

Product Characteristics

Color Size Imprint Code Shape
pink 19 mm ET OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-360-06 28 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA060359 2012-08-27


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.